Insulin Pump Market Insights $2.1B Revenue from Insulet, 500,000+ U.S. Users and 47.8% Adoption in Canada Driven by Government Funding
Ottawa, Feb. 06, 2026 (GLOBE NEWSWIRE) --
Over the past few years, the insulin pump market has experienced impressive growth, thanks to improvements in diabetes management technology and the rising number of people affected by diabetes. Insulin pumps, which offer a more consistent and accurate way to deliver insulin, have become essential for many living with Type 1 and Type 2 diabetes. As the market evolves, it’s important to understand how insulin pumps are priced, how they’re manufactured, and how sales are projected to grow. In this article, we’ll explore these key aspects, breaking down the expected sales volume, manufacturing costs, and price ranges from 2020 to 2035. By looking at these trends, we’ll get a clearer picture of where the insulin pump industry is headed and its growing role in diabetes
Insulin Pump Market Volume Table (2020–2035)
The volume table shows how many insulin pumps are expected to be sold globally each year, from 2020 to 2035. The sales volume is projected based on how much the insulin pumps cost on average. For example, if an insulin pump costs around $6,000 on average and the market value is $7.5 billion, we estimate around 1.5 million pumps are sold in that year. Over the next decade, as the market grows, more pumps are expected to be sold, with the market growing at a healthy pace.
Insulin Pump Market Manufacturing Price Range Table (2020–2035)
Manufacturing cost refers to what it takes to actually build an insulin pump, including the parts and labor required. The table shows the expected low cost for basic models and the high cost for advanced models. For example, a basic insulin pump might cost around $250 to manufacture, while a high-end model could cost up to $1,750. These values gradually increase over time because of inflation, technology upgrades, and better safety features.
Customize your insulin pump market report with detailed insights, including company revenues, adoption rates, and government reimbursement data, tailored to your specific needs and region @ https://www.towardshealthcare.com/download-sample/5025
Leading Players in the Insulin Pump Industry
Several companies dominate the insulin pump market, each with significant revenues tied to the sale of insulin pumps and related technologies. Let’s explore the financials and operational data of the leading players in the market:
Insulet Corporation
Medtronic Plc (Diabetes Division)
Ypsomed Holding
Tandem Diabetes Care
Medical Industries
Government and Health Authority Insights: Insulin Pump Usage and Accessibility
Beyond company data, government and health authority reports offer valuable insights into how insulin pumps are being adopted and reimbursed globally. These figures often reflect broader trends in diabetes care, accessibility to medical technology, and the evolution of healthcare reimbursement policies.
Canada
United States
Global Reimbursement Landscape
Type 1 Diabetes Usage Trends in the U.S.
Key Insights and Observations
Company Insights:
Government Insights:
Insulin Pump Market Forecast and Analysis (2026-2035)
The insulin pump market is forecast to grow at a CAGR of 9.65%, from USD 7.53 billion in 2025 to USD 18.93 billion by 2035, over the forecast period from 2026 to 2035. The market is expected to gain traction owing to industry players focus on the launch of technologically advanced CGM and insulin pumps.
Unlock tailored insights and solutions for your business with our customized insulin pump market report: https://www.towardshealthcare.com/checkout/5025
About Us
Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics, with a strong emphasis on life science research. Dedicated to advancing innovation in the life sciences sector, we build strategic partnerships that generate actionable insights and transformative breakthroughs. As a global strategy consulting firm, we empower life science leaders to gain a competitive edge, drive research excellence, and accelerate sustainable growth.
You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com
Europe Region: +44 778 256 0738
North America Region: +1 8044 4193 44
APAC Region: +91 9356 9282 04
Web: https://www.towardshealthcare.com
Find us on social platforms: LinkedIn | Twitter | Instagram | Medium | Pinterest